3 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 3 |
Follow Nevus: new trials by email Literature Review of Nevus trials Research Report on Nevus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin | Phase 3 | Recruiting | Memorial Sloan Kettering Cancer Center | 14000 | 2026-10-15 | 2026-10-22 |
| Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice - Advanced Melanoma | Phase 3 | Recruiting | Immunocore Ltd | 540 | 2022-12-19 | 2026-02-25 |
| The Cancer of the Pancreas Screening-5 CAPS5)Study Secretin, MRI, Tumor marker gene test with CA19-9 - Pancreas Cancer, Peutz-Jeghers Syndrome (PJS) | Phase 3 | Recruiting | Johns Hopkins University | 9000 | 2014-01-06 | 2026-10-22 |
Melanoma (2) · Breast Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Dysplastic Nevus Syndrome (1) · Hemangioma (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Hereditary pancreatitis (1) · Keratosis, Seborrheic (1) · Nevus, Blue (1) · Nevus, Pigmented (1) · Pancreatic Neoplasms (1) · Peutz-Jeghers Syndrome (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Nevi and Melanomas (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Skin Neoplasms (2) · Breast Diseases (1) · Colonic Diseases (1) · Colorectal Neoplasms (1)
CA-19-9 Antigen (1) · Secretin (1) · pembrolizumab (1) · tebentafusp (1)
Immunocore Ltd (1) · Johns Hopkins University (1) · Memorial Sloan Kettering Cancer Center (1)
United States (3) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Michael Goggins, MD (1) · Veronica Rotemberg, MD (1)
PMID 31197699, PMID 31676359, PMID 33161160, PMID 34149034
R01CA176828 (1), R01CA293974 (1), U01CA210170 (1)